An Updated View of the Trypanosoma cruzi Life Cycle: Intervention Points for an Effective Treatment

Frontiers Epidemiology of Trypanosomiasis in Wildlife—Implications for Humans at the Wildlife Interface in Africa

The Trypanosoma cruzi Proteome

Pathogen diversity, immunity, and the fate of infections: lessons learned from Trypanosoma cruzi human–host interactions - The Lancet Microbe

Modulation of miR-145-5p and miR-146b-5p levels is linked to reduced parasite load in H9C2 Trypanosoma cruzi infected cardiomyoblasts

Localized cardiac small molecule trajectories and persistent chemical sequelae in experimental Chagas disease

Antiproliferative effect of Pd-dppf-mpo in T. cruzi epimastigotes. a

New polyamine drugs as more effective antichagas agents than benznidazole in both the acute and chronic phases - ScienceDirect

Pathogens, Free Full-Text

Transcriptome analysis of alternative splicing in the pathogen life cycle in human foreskin fibroblasts infected with Trypanosoma cruzi

Chagas disease - The Lancet

An Updated View of the Trypanosoma cruzi Life Cycle: Intervention Points for an Effective Treatment - Kent Academic Repository

Frontiers Physical Exercise Promotes a Reduction in Cardiac Fibrosis in the Chronic Indeterminate Form of Experimental Chagas Disease

Frontiers Unveiling challenges in real-time PCR strategies for detecting treatment failure: observations from clinical trials on chronic Chagas disease

Cost-effectiveness of Chagas disease screening in Latin American migrants at primary health-care centres in Europe: a Markov model analysis - The Lancet Global Health

The life cycle of Trypanosoma cruzi. Note: Adapted from Centers for